MedTrace Logo

Breath Test for Early Detection of Lung Cancer

NCT00639067 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 215

Last updated 2014-05-16

No results posted yet for this study

Summary

To demonstrate and validate a breath test for detection of early stage lung cancer that could potentially reduce number of deaths.

Conditions

  • Lung Neoplasms

Interventions

DEVICE

Breath Collection Apparatus

Breath collected and analyzed for markers of lung cancer.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Menssana Research, Inc.

    lead INDUSTRY

Principal Investigators

  • Michael Phillips, MD, FACP · Menssana Research, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2012-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00639067 on ClinicalTrials.gov